Unichem Laboratories Limited

Unichem Laboratories Limited

Unichem Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with Regulation 74(5) for the quarter ended September 30, 2026.

Unichem Laboratories Limited

Unichem Laboratories Limited has informed the Exchange regarding USFDA Inspection At Goa Formulation Facility, where the inspection concluded with five observations related to procedural enhancements, and the company will provide a response within 15 days.

Unichem Laboratories Limited

Unichem Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Unichem Laboratories Limited

Unichem Laboratories Limited has received an Order-In-Appeal from Commissioner (Appeals Thane) regarding a cross charge of common services under the CGST Act, 2017, with a penalty of Rs. 87,07,09,556/- and interest liability of Rs. 6,58,76,590/-, which has been disallowed. The company will take remedial steps, including filing an appeal within prescribed timelines.

Unichem Laboratories Limited

Unichem Laboratories Limited has extended the exercise period for the options granted and vested under Unichem Employee Stock Option Scheme 2018.

Unichem Laboratories Limited

Unichem Laboratories Limited has responded to the National Stock Exchange's query regarding a significant increase in trading volume, stating that the surge is market-driven and that the company has made timely disclosures as required by SEBI regulations.

Unichem Laboratories Limited

Unichem Laboratories Limited has seen a significant increase in trading volume, prompting the exchange to seek clarification from the company.

Unichem Laboratories Limited

Unichem Laboratories Limited has submitted the Exchange a copy of the Srutinizers report of the shareholders meeting held on August 11, 2026. The company has informed the Exchange regarding voting results, with all resolutions passed with requisite majority.

Unichem Laboratories Limited

Unichem Laboratories Limited has informed the Exchange about Copy of Newspaper Publication - Financial Results for the quarter ended June 30, 2026, published in the newspapers on August 12, 2026

Unichem Laboratories Limited

Unichem Laboratories Limited held its 63rd Annual General Meeting on August 11, 2026, through video conference, where the company's financial statements and reports for the year ended March 31, 2026, were adopted, and several resolutions were passed, including the re-appointment of a director and the ratification of remuneration for the cost auditors.

Unichem Laboratories Limited

Unichem Laboratories Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 41.47 crores and a revenue from operations of Rs. 632.62 crores.

Unichem Laboratories Limited

Unichem Laboratories Limited has informed the Exchange about the partial allowance of their appeal filed for GSTR TRAN 1 credit by the Additional Commissioner, CGST, (Appeals), Dehradun, resulting in a demand of Rs. 10,59,354 plus interest.

Unichem Laboratories Limited

Unichem Laboratories Limited's promoters, IPCA Laboratories Limited, submitted a declaration under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, stating they have not made any encumbrance on the equity shares held in Unichem Laboratories Limited for the FY ended 31st March, 2026.

Unichem Laboratories Limited

Unichem Laboratories Limited has responded to a National Stock Exchange of India Limited (NSE) letter regarding significant price movement in the company's securities. The company claims to have complied with disclosure requirements and attributes the price increase to market forces.

Unichem Laboratories Limited

Unichem Laboratories Limited has experienced significant price movement, prompting the exchange to request information from the company to ensure investors have the latest relevant information.

Unichem Laboratories Limited

Unichem Laboratories Limited has submitted a compliance certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026, confirming that securities received for dematerialization were accepted or rejected and listed on stock exchanges.

Unichem Laboratories Limited

Unichem Laboratories Limited has informed the Exchange regarding disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has issued letters to shareholders whose email addresses are not registered with the company or depository participants, providing a web-link to access the Annual Report for the Financial Year 2025-26. The company also requests shareholders to update their KYC details and dematerialize physical securities.

Unichem Laboratories Limited

Unichem Laboratories Limited has informed the Exchange about a copy of newspaper publication regarding e-voting information for the 63rd Annual General Meeting of the Company.

Unichem Laboratories Limited

Unichem Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 11, 2026.

Unichem Laboratories Limited

Unichem Laboratories Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, detailing its corporate identity, business activities, operations, employees, and sustainability initiatives.